Concept · philosophy
End-of-life ethics
4 studiesEvidence last moved Sep 3, 2026
End-of-life ethics asks who may forgo life-sustaining treatment, how autonomy is shared with family and clinicians, and whether dying well means erasing all suffering.
Destination LVADs, East Asian statutes and palliative-care metrics all pressure the simple picture of an isolated chooser who wants zero pain.
Studies
4
Findings
4
4 supporting · 0 challenging · 0 qualifying citations
Open tensions
1
Latest change
Concept page published
End-of-life ethics
Currently
What we know
- Respect for autonomy remains central at the end of life, but decisions are better understood relationally in clinical context than as isolated choice characteristics.
- Japan, Korea, Taiwan and England regulate forgoing life-sustaining treatment differently, including how family is treated.
- Den Hartogh argues dying well can require respecting some suffering rather than only removing it as a symptom list.
- LVAD as destination therapy prolongs life in transplant-ineligible heart failure but reshapes dying, consent and caregiver burden.
Largest unresolved question
Relational-autonomy authors keep autonomy central; comparative statute work shows jurisdictions that still lack a forgoing-LST law or treat family as the decision site.
Common misconceptions
Palliative care’s aim is to drive suffering to zero.
Den Hartogh says studies cite Cassell then measure suffering like symptoms; dying well can include respecting some suffering.
Related
Claim ledger
What the evidence shows
Drawn from 4 studies in this library. Mix labels say which citation roles are present; they are not a strength score. Supports means evidence for a finding; Challenges means evidence against a stated position; Qualifies marks scope.
Respect for autonomy remains central at the end of life, but decisions are better understood relationally in clinical context than as isolated choice characteristics.
Japan, Korea, Taiwan and England regulate forgoing life-sustaining treatment differently, including how family is treated.
Den Hartogh argues dying well can require respecting some suffering rather than only removing it as a symptom list.
LVAD as destination therapy prolongs life in transplant-ineligible heart failure but reshapes dying, consent and caregiver burden.
Debates
Tensions and limits
Some items are genuine disagreements on the same question. Others mark different assays, populations, or outcomes.
Relational-autonomy authors keep autonomy central; comparative statute work shows jurisdictions that still lack a forgoing-LST law or treat family as the decision site.
Relational-autonomy authors keep autonomy central; comparative statute work shows jurisdictions that still lack a forgoing-LST law or treat family as the decision site.
Study Role Design N Population Outcome Is end-of-life autonomy only an isolated choice? Supports OtherRelational-autonomy ethics for end-of-life decisions, illustrated with a clinical vignette Normative clinical ethics; vignette is illustrative, not a sample N End-of-life and palliative shared decision-making about respecting autonomy Autonomy as relational and contextual rather than an isolated property of a choice Who may forgo life-sustaining treatment? Supports Qualitative / archivalComparative legal analysis of forgoing LST statutes in Japan, Korea, Taiwan, and England N=4 · Four jurisdictions compared End-of-life LST withdrawal/ACP regulations in Japan, Korea, Taiwan, and England Sharp differences in family vs patient roles and statutory coverage of forgoing LST
PaperFren reads this as a limit on how far one study travels — different assays, populations, or outcomes — not a forced fight between papers.
Timeline
How understanding moved
Study years are when the paper was published. Evidence edits are dated changes to this page's claims. Explanations are when PaperFren added a Discovery — not a claim that the science happened that day.
2026
Concept page published
End-of-life ethics
Change log
What changed
Dated edits to this page's evidence: studies added or removed from a claim, claims added or withdrawn, and new explanations tagged here. Rewordings are not listed.
- Concept page published
Papers
4 studies in this library bear on End-of-life ethics, ordered by citations.
- What ethics does a permanent heart pump raise?
LVAD as destination therapy prolongs life in transplant-ineligible heart failure, but it also reshapes dying, consent, and caregiver burden.
- Is end-of-life autonomy only an isolated choice?
The authors treat respect for autonomy as central at the end of life but argue decisions are better understood relationally, in clinical context, not as isolated characteristics of a choice.
- Who may forgo life-sustaining treatment?
East Asian statutes on withdrawing LST differ sharply from England: Japan still lacked a forgoing-LST law after a decade of debate; Korea and Taiwan legislated withdrawal; England treats family differently in the comparative analysis.
- Should palliative care erase all suffering?
Den Hartogh says end-of-life studies cite Cassell but then measure suffering like a symptom list; dying well can require respecting some suffering, not only removing it.
Compare studies
Select 2–10 studies. Design and N are labels, not a ranking.
Nothing selected yet.
Questions
What is still open
Relational-autonomy authors keep autonomy central; comparative statute work shows jurisdictions that still lack a forgoing-LST law or treat family as the decision site.
Ask PaperFren about End-of-life ethics
Study this conceptflashcards and short-answer questions
What is relational autonomy at the end of life?
Autonomy exercised in relationships and clinical context, not as an isolated property of a single choice.
Give one legal contrast from the forgoing-LST comparison.
After a decade of debate Japan still lacked a forgoing-LST law, while Korea and Taiwan legislated withdrawal and England treats family differently.